World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 7 January 2013
Main ID:  NCT01329614
Date of registration: 14/10/2010
Primary sponsor: New York State Psychiatric Institute
Public title: Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving
Scientific title: Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving
Date of first enrolment: October 2009
Target sample size: 40
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01329614
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Laura R Shiffrin, BFA
Address: 
Telephone: 212-543-6005
Email: shiffri@nyspi.columbia.edu
Affiliation: 
Name:   S. Rob Vorel, M.D., Ph.D.
Address: 
Telephone:
Email:
Affiliation:  New York State Psychiatric Institute, Substance Use Research Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- A DSM-IV Diagnosis of nicotine dependence with physiological dependence. Smoke at
least 15 cigarettes daily for two years.

- Not interested in treatment.

- Medically healthy on the basis of physical examination and medical history, vital
signs, EKG and laboratory tests, with a negative pregnancy test for females.

- Able to perform study procedures.

- Males or females between the ages of 21-60 years.

- Female participants agree to use an effective method of birth control during the
course of the study.

Exclusion Criteria:

- A DSM-IV diagnosis of abuse or dependence on alcohol or drugs other than nicotine.

- Current Axis I diagnosis or current treatment with psychotropic medications (within
last 3 months).

- Lifetime history of schizophrenia or other psychotic disorders, bipolar disorder, or
anxiety disorders.

- Seeking treatment for nicotine dependence.

- Participants on parole or probation.

- History of significant recent violent behavior.

- Unstable medical condition, Blood Pressure > 150/90, Pregnancy.

- History of allergic reaction to nicotine patch.

- Participants with significant cardiac history (i.e. angina pectoris, bypass surgery,
or coronary artery disease.)



Age minimum: 21 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Tobacco Use Disorder
Intervention(s)
Behavioral: Cue Extinction Therapy
Behavioral: Cue Extinction Training
Behavioral: Progressive Muscle Relaxation
Drug: Nicotine Replacement Therapy
Primary Outcome(s)
Galvanic Skin Response [Time Frame: 3 days, over the course of 4-5 weeks total.]
Secondary Outcome(s)
Secondary ID(s)
6001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history